Clinical trials
Phase 2 Urinary Bladder, Overactive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Terminated | 9 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Buddhist Tzu Chi General Hospital | 5 |
| Pfizer | 5 |
| Allergan | 3 |
| Bayer | 3 |
| GlaxoSmithKline | 3 |
| Ono Pharmaceutical Co., Ltd. | 3 |
| Astellas Pharma Europe B.V. | 2 |
| Astellas Pharma Inc | 2 |
| Loyola University | 2 |
| Sanofi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder, Overactive | 67 |
| Urinary Incontinence | 14 |
| Urinary Incontinence, Urge | 11 |
| Spinal Cord Injuries | 4 |
| Lower Urinary Tract Symptoms | 2 |
| Multiple Sclerosis | 2 |
| Cognitive Dysfunction | 1 |
| Fecal Incontinence | 1 |
| Heart Failure | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
Trials
Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.